KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Net Margin (2016 - 2025)

Resmed (RMD) has disclosed Net Margin for 17 consecutive years, with 27.59% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 71.0% year-over-year to 27.59%, compared with a TTM value of 27.53% through Dec 2025, up 218.0%, and an annual FY2025 reading of 27.22%, up 543.0% over the prior year.
  • Net Margin was 27.59% for Q4 2025 at Resmed, up from 26.1% in the prior quarter.
  • Across five years, Net Margin topped out at 28.36% in Q1 2021 and bottomed at 17.96% in Q4 2023.
  • Average Net Margin over 5 years is 23.61%, with a median of 22.53% recorded in 2021.
  • The sharpest move saw Net Margin tumbled -765bps in 2022, then soared 892bps in 2024.
  • Year by year, Net Margin stood at 22.55% in 2021, then dropped by -3bps to 21.76% in 2022, then fell by -17bps to 17.96% in 2023, then skyrocketed by 50bps to 26.88% in 2024, then increased by 3bps to 27.59% in 2025.
  • Business Quant data shows Net Margin for RMD at 27.59% in Q4 2025, 26.1% in Q3 2025, and 28.17% in Q2 2025.